Skip to main content
Clinical Trials/CTRI/2023/12/060615
CTRI/2023/12/060615
Not yet recruiting
Phase 2

Comparison of effects of intravenous Midazolam (0.035mg/kg)-Fentanyl(50mcg) combination and intravenous Dexmedetomidine (0.75mcg/kg)in flexible bronchoscopy - NI

DrSravya putta0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
DrSravya putta
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DrSravya putta

Eligibility Criteria

Inclusion Criteria

  • All patients in the age group 18 to 60 years undergoing flexible bronchoscopy in the department of respiratory medicine

Exclusion Criteria

  • 1\. Patients with known or suspected allergy to Midazolam or Dexmedetomidine.
  • 2\. Patients with renal impairment
  • 3\. Patients with hepatic impairment
  • 4\. Patients with seizure disorder.
  • 5\. COPD patients with Forced Expiratory Volume (FEV1\) \< 50%.
  • 6\. Patients with psychiatric illness.
  • 7\. Hemodynamic instability including cardiac failure.
  • 8\. Second\- or third\-degree heart block/ Heart rate \<50/min
  • 9\. Patients weighing less than 50kg or more than 70kg.
  • 10\. Pregnancy and lactation.

Outcomes

Primary Outcomes

Not specified

Similar Trials